Ocugen Revenue, Growth & Competitor Profile

DBA OCUGEN OPCO, INC.

Company Profile & Annual Report for Ocugen

Access the complete profile.

Ocugen Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 325414 Biological Product Manufacturing
Address	11 Great Valley Pkwy Malvern, PA 19355

Note: Revenues for privately held companies are statistical evaluations.


Ocugen's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ocugen's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Ocugen is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Ocugen Annual Revenue and Growth Rate

Ocugen	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ocugen's revenues are gauged from an analysis of company filings.

Ocugen's Income Statement (based on Industry Averages)

Ocugen P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Ocugen has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
November 19, 2018	4	9%	$4 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Ocugen is developing and marketing. Ocugen doesn't have any recent trademark applications, indicating Ocugen is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
OCUGEN House mark for pharmaceutical preparations for treating diseases and disorders affecting the eye	01/04/2017
NEOCART living biological tissue grown and regenerated ex vivo for subsequent implantation inter vivo - namely, cartilaginous tissues, collagen, ligaments and tendons and epithelial tissues	05/09/2012
H HISTOGENICS Living biological tissue grown and regenerated ex vivo for subsequent implantation inter vivo, namely, cartilaginous tissues, collagen, ligaments and tendons and epithelial tissues	07/25/2006

See all trademarks and details in the Full Report.

Market Share of Ocugen's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ocugen, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Ocugen. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ENDO PHARMACEUTICALS	Malvern, PA	100
FRONTAGE LABORATORIES	Exton, PA	73
NEURONETICS	Malvern, PA	21
REACTION BIOLOGY	Malvern, PA	16
ALLIANCE PHARMA	Malvern, PA	14
OCUGEN	Malvern, PA	10

Future Competition: Ocugen's Fastest Growing Competitors

These companies are in the same general field as Ocugen and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)